Reference

1. Betty Y. S. Kim, M.D, et al. Nanomedicine.  The new england Journal of medicine N Engl J med 2010; 363 :2434-2443 DOI: 10.1056/NEJMra 0912273 December 16, (2010) page no.2434-2443
2. Kristina Riechelmann, Stefan W. schneider, et al. Nanomedicine-Challenge and Perspectives Angew chem Int Ed Eng. Author manuscript available in PMC 2014 Sep 26. published in final edited form as Angew chem Int Ed. Eng 2009;48(5):872-897 doi:10.1002/anie.
3. Klaudia Dynarowicz, David Aebisher Nanomedicine – a review European Journal of Clinical and Experimental Medicine Eur J Clin Exp Med. ISSN 2544-1361 doi: 10.15584/ejcem.2022.1.14 Received: 30.12.2021 / Revised: 10.02.2022 / Accepted: 13.02.2022 / Published: 30.03.2022
4. DebjitvBhowmik1, Chiranjib, R. Margret, et al. Nanomedicine-An Overview International Journal of PharmTech Research CODEN(USA): IJPRIF ISSN: 0974-4304 Vol.2, No.4, pp 2143-2151 Oct-Dec 2010
5. Moni Saha Nanomedicine: Promising Tiny Machine for the Healthcare in Future Saha.M.OMJ.24,242-247(2009); doi:10.5001/omj.2009.50
6. Roy Gaurab Yadav Amit Nanomedicine: Therapeutic Applications and Limitations DOI:10.4018/978-1-4666-6363-3.ch005
7. Kenza Snoussi and Michael Kann Nanomedicine General Considerations and Examples page no.129-133
8. European Science Foundation (ESF). 2004. Nanomedicine—An ESF–European Medical Research Councils (EMRC) Forward Look Report. Strasbourg cedex, France
9. Sara Soares 1, João Sousa1,2, Nanomedicine: Principles, Properties, and Regulatory Issues doi: 10.3389/fchem.2018.00360 
10. Patrick BOISSEAU*1, Bertrand LOUBATON2 Nanomedicine, Nanotechnology in medicine HAL Id: hal-00598930 https://hal.science/hal-00598930
11.  K. John Morrow, Jr, Ph Da, Raj Bawa, Recent Advances in Basic and Clinical Nanomedicine doi: 10.1016/j.mcna.2007.05.009
12. Islam Ahmed Hamed Khalil, Islam A. Arid Introductory Chapter: Overview on Nanomedicine Market DOI: 10.5772/intechopen.91890
13. Saad S. M. Hassan, [a] Ayman H. Kamel, Heba M. Hashem[a] DRUG DELIVERY SYSTEMS BETWEEN METAL, LIPOSOME, AND POLYMER-BASED NANOMEDICINE: A REVIEW DOI: http://dx.doi.org/10.17628/ecb.2020.9.91-102
14. Weiwei Gao, Che-Ming J. Hu, Ronnie H. Fang Liposome-like Nanostructures for Drug Delivery Mater Chem B Mater Biol Med 2013 December 28; 1(48): . doi:10.1039/C3TB21238F.
15. Foad Rommasi and Neda Esfandiari*Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapyhttps://doi.org/10.1186/s11671-021-03553-8
16. Filipe Fernandes 1, Mónica Dias-Teixeira 1,2, Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts https://doi.org/10.3390/nano11030563
17. Jae Hyung Park a 1, Seulki Lee b copolymeric nanomedicine for cancer therapyhttps://doi.org/10.1016/j.progpolymsci.2007.09.003
18. Hongyun Lu1, Shengliang Zhang1, Jinling Wang2* and Qihe Chen1*A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems doi: 10.3389/fnut.2021.783831
19. Agha Zeeshan Mirza • Farhan Ahmed Siddiqui Nanomedicine and drug delivery: a mini review DOI 10.1007/s40089-014-0094-7
20. Young Hee Choi1. Hyo Kyung Han1 Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics Journal of Pharmaceutical Investigate on https://doi.org/10.1007/s40005-017-0370-4
21. Debasis Bera *, Lewisian, Quantum Dots and Their Multimodal Applications: A Review Materials 2010, 3, 2260-2345; doi:10.3390/ma3042260
22. Kushagra Agarwal, Himanshu Rai and Sandip Mondal Quantum dots: an overview of synthesis, properties, and  applicationshttps://doi.org/10.1088/2053-1591/acda17
23. PARIJAT PANDEY, MANDEEP DAHIYA *A BRIEF REVIEW ON INORGANIC NANOPARTICLES Journal of Critical Reviews ISSN- 2394-5125 Vol 3, Issue 3, 2016
24. Aaron C. Anselmo1 and Samir Mitragotri1,2A Review of Clinical Translation of Inorganic Nanoparticles DOI: 10.1208/s12248-015-9780-2
25. M. Joyce Nirmala, a Uma Kizhuveetil, et al. Cancer nanomedicine: a review of nano-therapeutics and challenges ahead Received 9th December 2022 Accepted 7th March 2023 DOI: 10.1039/d2ra07863e
26. Ruibing Wang, Paul S. Billone, et al. Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical Trials Volume 2013, Article ID 629681, 12 pages Received 22 October 2012; Accepted 9 November 2012
27. Esteban Beltrán Gracia1, Adolfo López Camacho1, et al. Nanomedicine review: Beltrán Gracia Nanomedicine review: clinical developments in liposomal applications Beltrán Gracia. Cancer Nano (2019) 10:11https://doi.org/10.1186/s12645-019-0055-y
28. Mrs. K. Usha Rani Review Article Nanomedicine JNPE, JUNE 2017, Vol. 3, Issue 2, pp.37–40 ISSN No.2395-1974 on 16-January-2020 https://www.researchgate.net/publication/338621537
29. Wesam R Kadhum1, Muqdad Alhijjaj2, et al. Nanomedicine and Drug Delivery Systems: Roles, Advantages and Disadvantages International Journal of Current Pharmaceutical Review and Research 2022; 14(4); 1-6 ISSN: 0976-822XReceived: 14-11-2022 / Revised: 25-11-2022 / Accepted: 05-12-2022www.ijcpr.com
30. Raj Kumar Thapa1 · Jong Oh Kim2Nanomedicine based commercial formulations: current developments and future prospects Journal of Pharmaceutical Investigation (2023) 53:19–33 https://doi.org/10.1007/s40005-022-00607-6 Received: 21 November 2022 / Accepted: 10 December 2022 / Published online: 19 December 2022
31. Jayanta Kumar Patra1 , Giti Shree Das1,etal.Nano based drug delivery systems: recent developments and future prospects, published by Journal of Nanobiotechnology (2018)  16:71 https://doi.org/10.1186/s12951-018-0392-8
32. Zbynek Heger1, Sylvie Skalickova, et al. Apoferritin applications in nanomedicine 10.2217/NNM.14.119 © 2014 Future Medicine Ltd. (2014) 9(14), 2233–2245 ISSN 1743–5889-pageno.2233.